Detection of amiodarone-induced pulmonary toxicity in supine and prone positions - High-resolution computed tomography study

Circulation Journal

Volumn 69, Issue 4, 2005, Pages 466-470

  Oyama, Noriko ^a   Oyama, Naotsugu ^a   Yokoshiki, Hisashi ^a   Kamishima, Tamotsu ^a   Nambu, Toshikazu ^a   Tsutsui, Hiroyuki ^a   Miyasaka, Kazuo ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Amiodarone; High resolution computed tomography; Prone position; Pulmonary toxicity; Supine position

Indexed keywords

AMIODARONE;

ADULT; AGED; ARTICLE; BODY POSTURE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; FEMALE; HEART ARRHYTHMIA; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG DISEASE; LUNG TOXICITY; MALE; PROSPECTIVE STUDY; REPRODUCIBILITY; SUPINE POSITION;

ADULT; AGED; AMIODARONE; ANTIGENS; ANTIGENS, NEOPLASM; DIAGNOSIS, DIFFERENTIAL; FALSE POSITIVE REACTIONS; FEMALE; GLYCOPROTEINS; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; MUCINS; PRONE POSITION; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SUPINE POSITION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 17044379550     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.69.466     Document Type: Article

References (24)

1. Singh BN, Vaughan Williams EM. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol 1970; 39: 657-667.
2. Connolly SJ. Evidenced-based analysis of amiodarone efficacy and safety. Circulation 1999; 100: 2025-2034.
3. Aiba T, Kurita T, Taguchi A, Shimizu W, Suyama K, Aihara N, et al. Long-term efficacy of empirical chronic amiodarone therapy in patients with sustained ventricular tachyarrhythmia and structural heart disease. Circ J 2002; 66: 367-371.
4. Shiga T, Wakaumi M, Imai T, Suzuki T, Hosaka F, Yamada Y, et al. Effect of low-dose amiodarone on atrial fibrillation or flutter in Japanese patients with heart failure. Circ J 2002; 66: 600-604.
5. Vrobel TR, Miller PE, Mostow ND, Rakita L. A general overview of amiodarone toxicity: Its prevention, detection, and management. Prog Cardiovasc Dis 1989; 31: 393-426.
6. Marchlinski FE, Gansler TS, Waxman HL, Josephson ME. Amiodarone pulmonary toxicity. Ann Intern Med 1982; 97: 839-845.
7. Vorperian VR, Havighurst TC, Miller S, January CT. Adverse effects of low dose amiodarone: A meta-analysis. J Am Coll Cardiol 1997; 30: 791-798.
8. Kuhlman JE, Scatarige JC, Fishman EK, Zerhouni EA, Siegelman SS. CT demonstration of high attenuation pleural-parenchymal lesions due to amiodarone therapy. J Comput Assist Tomogr 1987; 11: 160-162.
9. Ren H, Kuhlman JE, Hruban RH, Fishman EK, Wheeler PS, Hutchins GM. CT-pathology correlation of amiodarone lung. J Comput Assist Tomogr 1990; 14: 760-765.
10. Nicholson AA, Hayward C. The value of computed tomography in the diagnosis of amiodarone-induced pulmonary toxicity. Clin Radiol 1989; 40: 564-567.
11. Standertskjold-Nordenstam CG, Wandtke JC, Hood WB Jr, Zugibe FT, Butler L. Amiodarone plumonary toxicity: Chest radiography and CT in asymptomatic patients. Chest 1985; 88: 143-145.
12. Butler S, Smathers RL. Computed tomography of amiodarone plumonary toxicity. J Comput Assist Tomogr 1985; 9: 375-376.
13. Kuhlman JE, Teigen C, Ren H, Hruban RH, Hutchins GM, Fishman EK, et al. Amiodarone pulmonary toxicity: CT findings in symptomatic patients. Radiology 1990; 177: 121-125.
14. Padley SP, Adler B, Hansell DM, Muller NL. High-resolution computed tomography of drug-induced lung disease. Clin Radiol 1992; 46: 232-236.
15. Vernhet H, Bousquet C, Durand G, Giron J, Senac JP. Reversible amiodarone-induced lung disease: HRCT findings. Eur Radiol 2001; 11: 1697-1703.
16. Siniakowicz RM, Narula D, Suster B, Steinberg JS. Diagnosis of amiodarone pulmonary toxicity with high-resolution computerized tomographic scan. J Cardiovasc Electrophysiol 2001; 12: 431-436.
17. Aberle DR, Gamsu G, Ray CS, Feuerstein IM. Asbestos-related pleural and parenchymal fibrosis: Detection with high-resolution CT. Radiology 1988; 166: 729-734.
18. Volpe J, Storto ML, Lee K, Webb WR. High resolution CT of the lung parenchyma. AJR 1997; 169: 369-374.
19. Nakajima M, Kawahara Y, Yoshida K, Miyashita N, Niki Y, Matsushima T. Serum KL-6 as a possible marker for amiodarone-induced pulmonary toxicity. Intern Med 2000; 39: 1097-1100.
20. Endoh Y, Hanai R, Uto K, Uno M, Nagashima H, Narimatsu A, et al. KL-6 as apotential new marker for amiodarone induced pulmonary toxicity. Am J Cardiol 2000; 86: 229-231.
21. Dusman RE, Stanton MS, Miles WM, Klein LS, Zipes DP, Fineberg NS, et al. Clinical features of amiodarone-induced pulmonary toxicity. Circulation 1990; 82: 51-59.
22. Stelfox HT, Ahmed SB, Fiskio J, Bates DW. Monitoring amiodarone's toxicities: Recommendations, evidence, and clinical practice. Clin Pharmacol Ther 2004; 75: 110-122.
23. Camus P, Martin WJ 2nd, Rosenow EC 3rd. Amiodarone pulmonary toxicity. Clin Chest Med 2004; 25: 65-75.
24. Friedman AC, Fiel SB, Fisher MS, Radecki PD, Lev-Toaff AS, Caroline DF. Asbestos-related pleural disease and asbestosis: A comparison of CT and chest radiography. AJR 1998; 150: 269-275.